Authors:
HILL S
HOLMES CL
SHIELDS JG
MCLEAN CS
ENTWISLE C
BLAKELEY D
BOURSNELL MEG
HICKLING JK
Citation: S. Hill et al., USE OF A DISABLED INFECTIOUS SINGLE-CYCLE (DISC) HERPES-SIMPLEX VIRUS(HSV) AS A VECTOR FOR THE INDUCTION OF IMMUNE-RESPONSES TO PRODUCTS OF HETEROLOGOUS GENES, Journal of leukocyte biology, 1998, pp. 14-14
Authors:
BOURSNELL MEG
ENTWISLE C
ALI SA
SIVASUBRAMANIAM SD
REEDER S
MCLEAN CS
BLAKELEY DM
SHIELDS JG
INGLIS SC
REES RC
Citation: Meg. Boursnell et al., DISABLED INFECTIOUS SINGLE-CYCLE (DISC) HERPES-SIMPLEX VIRUS AS A VECTOR FOR IMMUNOTHERAPY OF CANCER, Cancer gene therapy, 4(5), 1997, pp. 321-321
Authors:
BOURSNELL MEG
ENTWISLE C
BLAKELEY D
ROBERTS C
DUNCAN IA
CHISHOLM SE
MARTIN GM
JENNINGS R
CHALLANAIN DN
SOBEK I
INGLIS SC
MCLEAN CS
Citation: Meg. Boursnell et al., A GENETICALLY INACTIVATED HERPES-SIMPLEX VIRUS TYPE-2 (HSV-2) VACCINEPROVIDES EFFECTIVE PROTECTION AGAINST PRIMARY AND RECURRENT HSV-2 DISEASE, The Journal of infectious diseases, 175(1), 1997, pp. 16-25
Authors:
BOURSNELL MEG
RUTHERFORD E
HICKLING JK
ROLLINSON EA
MUNRO AJ
ROLLEY N
MCLEAN CS
BORYSIEWICZ LK
VOUSDEN K
INGLIS SC
Citation: Meg. Boursnell et al., CONSTRUCTION AND CHARACTERIZATION OF A RECOMBINANT VACCINIA WAS EXPRESSING HUMAN PAPILLOMAVIRUS PROTEINS FOR IMMUNOTHERAPY OF CERVICAL-CANCER, Vaccine, 14(16), 1996, pp. 1485-1494
Authors:
MCLEAN CS
NICHALLANAIN D
DUNCAN I
BOURSNELL MEG
JENNINGS R
INGLIS SC
Citation: Cs. Mclean et al., INDUCTION OF A PROTECTIVE IMMUNE-RESPONSE BY MUCOSAL VACCINATION WITHA DISC HSV-1 VACCINE, Vaccine, 14(10), 1996, pp. 987-992
Authors:
HICKLING JK
BOURSNELL MEG
RUTHERFORD E
ROLLINSON E
MCLEAN CS
STACEY S
BORYSIEWICZ LK
INGLIS SC
Citation: Jk. Hickling et al., CONSTRUCTION OF A RECOMBINANT VACCINIA VIRUS EXPRESSING HPV TYPES-16 AND TYPE-18, TYPE-EL AND TYPE-E7 FOR IMMUNOTHERAPY OF CERVICAL-CARCINOMA, Journal of cellular biochemistry, 1995, pp. 311-311
Authors:
MCLEAN CS
DUNCAN IA
CHISHOLM SE
BOLT SL
BOURSNELL MEG
INGLIS SC
MINSON AC
SHIELDS JG
Citation: Cs. Mclean et al., LONG-TERM PROTECTION FOLLOWING VACCINATION WITH A GH-DELETED HERPES-SIMPLEX VIRUS TYPE-1, Journal of cellular biochemistry, 1995, pp. 312-312
Authors:
FARRELL HE
MCLEAN CS
HARLEY C
EFSTATHIOU S
INGLIS S
MINSON AC
Citation: He. Farrell et al., VACCINE POTENTIAL OF A HERPES-SIMPLEX VIRUS TYPE-1 MUTANT WITH AN ESSENTIAL GLYCOPROTEIN DELETED, Journal of virology, 68(2), 1994, pp. 927-932
Authors:
MCLEAN CS
ERTURK M
JENNINGS R
NICHALLANAIN D
MINSON AC
DUNCAN I
BOURSNELL MEG
INGLIS SC
Citation: Cs. Mclean et al., PROTECTIVE VACCINATION AGAINST PRIMARY AND RECURRENT DISEASE CAUSED BY HERPES-SIMPLEX VIRUS (HSV) TYPE-2 USING A GENETICALLY DISABLED HSV-1, The Journal of infectious diseases, 170(5), 1994, pp. 1100-1109
Citation: Jr. Broussard et Cs. Mclean, AN ALGORITHM FOR SIMULTANEOUS STABILIZATION USING DECENTRALIZED CONSTANT GAIN OUTPUT-FEEDBACK, IEEE transactions on automatic control, 38(3), 1993, pp. 450-455